Marsden DL - Search Results

1

Maculopathy and retinal degeneration in cobalamin C methylmalonic aciduria and homocystinuria.

Tsina EK, Marsden DL, Hansen RM, Fulton AB. Tsina EK, et al. Among authors: marsden dl. Arch Ophthalmol. 2005 Aug;123(8):1143-6. doi: 10.1001/archopht.123.8.1143. Arch Ophthalmol. 2005. PMID: 16087854 No abstract available.

2

Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an examination of the medical and neurodevelopmental characteristics of 14 cases identified through newborn screening or clinical symptoms.

Waisbren SE, Levy HL, Noble M, Matern D, Gregersen N, Pasley K, Marsden D. Waisbren SE, et al. Mol Genet Metab. 2008 Sep-Oct;95(1-2):39-45. doi: 10.1016/j.ymgme.2008.06.002. Epub 2008 Aug 3. Mol Genet Metab. 2008. PMID: 18676165 Free PMC article.

3

X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype.

Anselm IA, Alkuraya FS, Salomons GS, Jakobs C, Fulton AB, Mazumdar M, Rivkin M, Frye R, Poussaint TY, Marsden D. Anselm IA, et al. J Inherit Metab Dis. 2006 Feb;29(1):214-9. doi: 10.1007/s10545-006-0123-4. J Inherit Metab Dis. 2006. PMID: 16601897 Free PMC article.

4

Expanded newborn screening by tandem mass spectrometry: the Massachusetts and New England experience.

Marsden D. Marsden D. Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:111-4. Southeast Asian J Trop Med Public Health. 2003. PMID: 15906712

5

Expanded newborn screening.

Fearing MK, Marsden D. Fearing MK, et al. Pediatr Ann. 2003 Aug;32(8):509-15. doi: 10.3928/0090-4481-20030801-08. Pediatr Ann. 2003. PMID: 12942893

6

Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects.

Browning MF, Larson C, Strauss A, Marsden DL. Browning MF, et al. Among authors: marsden dl. J Inherit Metab Dis. 2005;28(4):545-50. doi: 10.1007/s10545-005-0545-4. J Inherit Metab Dis. 2005. PMID: 15902557

7

New England Consortium: a model for medical evaluation of expanded newborn screening with tandem mass spectrometry.

Albers S, Waisbren SE, Ampola MG, Brewster TG, Burke LW, Demmer LA, Filiano J, Greenstein RM, Ingham CL, Korson MS, Marsden D, Schwartz RC, Seashore MR, Shih VE, Levy HL. Albers S, et al. J Inherit Metab Dis. 2001 Apr;24(2):303-4. doi: 10.1023/a:1010391623104. J Inherit Metab Dis. 2001. PMID: 11405349 No abstract available.

8

Newborn screening for metabolic disorders.

Marsden D, Larson C, Levy HL. Marsden D, et al. J Pediatr. 2006 May;148(5):577-584. doi: 10.1016/j.jpeds.2005.12.021. J Pediatr. 2006. PMID: 16737864 Review. No abstract available.

9

The knowledge gap in expanded newborn screening: survey results from paediatricians in Massachusetts.

Gennaccaro M, Waisbren SE, Marsden D. Gennaccaro M, et al. J Inherit Metab Dis. 2005;28(6):819-24. doi: 10.1007/s10545-005-0135-5. J Inherit Metab Dis. 2005. PMID: 16435173

10

Clinical picture: Multicolour karyotyping.

Lee C, Murray MF, Miron PM, Marsden D, Irons M, Wilkins-Haug LE, Morton CC. Lee C, et al. Lancet. 2001 Apr 21;357(9264):1240. doi: 10.1016/s0140-6736(00)04472-x. Lancet. 2001. PMID: 11458963 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results